Sinopharm Capital
Overview
国药资本管理有限公司是国药集团发起设立的专注于医疗健康领域的专业股权投资机构，管理团队由国药集团内外部专业投资人士按照市场化机制组成。对医疗健康行业发展、产业运营和资本运作理解深刻，能有效整合国药集团内外部行业资源和资本力量。 国药资本坚守产业资本的责任与情怀，秉承“真诚、专业、共赢”的企业文化，立志成为中国医疗健康产业价值的发现者、挖掘者、整合者和实现者，通过聚焦于行业细分领域有创新性和成长…
Reach Sinopharm Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Sinopharm Capital
What sectors does Sinopharm Capital invest in?
Sinopharm Capital invests in Financial Services, Healthcare, Pharmaceuticals, Medical Devices, Biotechnology and Consumer Health, and is based in Shanghai, China. Sinopharm Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Sinopharm Capital invest at?
Sinopharm Capital backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout.
Which regions does Sinopharm Capital invest in?
Sinopharm Capital invests across China.
How do I contact Sinopharm Capital?
Sinopharm Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
